Published in J Infect Dis on July 13, 2001
Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol (2007) 3.19
Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis (2012) 2.22
Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol (2005) 2.21
The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev (2011) 2.05
Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev (2005) 1.94
Animal pneumoviruses: molecular genetics and pathogenesis. Clin Microbiol Rev (2004) 1.67
Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol (2009) 1.65
Human metapneumovirus induces a profile of lung cytokines distinct from that of respiratory syncytial virus. J Virol (2005) 1.44
Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats. J Virol (2005) 1.42
A mechanistic role for type III IFN-λ1 in asthma exacerbations mediated by human rhinoviruses. Am J Respir Crit Care Med (2011) 1.31
Human genetic factors and respiratory syncytial virus disease severity. Clin Microbiol Rev (2008) 1.30
Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo. J Virol (2004) 1.28
Reduced clearance of respiratory syncytial virus infection in a preterm lamb model. Microbes Infect (2004) 1.27
Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection. J Immunol (2010) 1.26
CXCL10/CXCR3-mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8(+) T cell efficacy. Eur J Immunol (2008) 1.22
Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus. J Biol Chem (2008) 1.19
New insights for development of a safe and protective RSV vaccine. Hum Vaccin (2010) 1.18
Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model. Virol J (2005) 1.18
Respiratory syncytial virus vaccine development. Expert Rev Vaccines (2011) 1.18
IkappaB kinase is a critical regulator of chemokine expression and lung inflammation in respiratory syncytial virus infection. J Virol (2004) 1.09
Respiratory syncytial virus synergizes with Th2 cytokines to induce optimal levels of TARC/CCL17. J Immunol (2007) 1.09
Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents. J Virol (2003) 1.08
Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. J Exp Med (2015) 1.03
Decreased interferon-gamma response in respiratory syncytial virus compared to other respiratory viral infections in infants. Clin Exp Immunol (2004) 1.02
Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med (2011) 1.02
Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway. J Immunol (2011) 1.00
Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients. Semin Respir Crit Care Med (2011) 1.00
Respiratory syncytial virus F and G proteins induce interleukin 1alpha, CC, and CXC chemokine responses by normal human bronchoepithelial cells. J Infect Dis (2010) 0.99
Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities. Antioxid Redox Signal (2012) 0.97
Pulmonary eosinophils and their role in immunopathologic responses to formalin-inactivated pneumonia virus of mice. J Immunol (2009) 0.96
Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection. Pediatr Infect Dis J (2013) 0.96
The chemokine MIP1alpha/CCL3 determines pathology in primary RSV infection by regulating the balance of T cell populations in the murine lung. PLoS One (2010) 0.96
Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model. Gut (2005) 0.95
Efficient replication of pneumonia virus of mice (PVM) in a mouse macrophage cell line. Virol J (2007) 0.95
STAT1 negatively regulates lung basophil IL-4 expression induced by respiratory syncytial virus infection. J Immunol (2009) 0.94
Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics. Curr Med Chem (2012) 0.93
Cigarette smoke condensate enhances respiratory syncytial virus-induced chemokine release by modulating NF-kappa B and interferon regulatory factor activation. Toxicol Sci (2008) 0.91
Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants. Am J Physiol Lung Cell Mol Physiol (2013) 0.90
Bench-to-bedside review: rare and common viral infections in the intensive care unit--linking pathophysiology to clinical presentation. Crit Care (2008) 0.90
Respiratory syncytial virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice. Respir Res (2010) 0.89
TAK1 regulates NF-ΚB and AP-1 activation in airway epithelial cells following RSV infection. Virology (2011) 0.88
Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection. Am J Respir Cell Mol Biol (2014) 0.86
The role of Th17 and Treg responses in the pathogenesis of RSV infection. Pediatr Res (2015) 0.86
Ataxia telangiectasia mutated kinase mediates NF-κB serine 276 phosphorylation and interferon expression via the IRF7-RIG-I amplification loop in paramyxovirus infection. J Virol (2014) 0.84
Local production of inflammatory mediators during childhood parainfluenza virus infection. Pediatr Infect Dis J (2010) 0.84
Cellular and humoral immunity of virus-induced asthma. Front Microbiol (2013) 0.81
Depletion of alveolar macrophages prolongs survival in response to acute pneumovirus infection. Virology (2011) 0.81
Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants. PLoS One (2015) 0.80
Altered Treg and cytokine responses in RSV-infected infants. Pediatr Res (2016) 0.80
Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine. PLoS One (2012) 0.80
Differential response of BDCA-1+ and BDCA-3+ myeloid dendritic cells to respiratory syncytial virus infection. Respir Res (2013) 0.78
Lung dendritic cell developmental programming, environmental stimuli, and asthma in early periods of life. J Allergy (Cairo) (2012) 0.77
The Role of Human Milk Immunomodulators in Protecting Against Viral Bronchiolitis and Development of Chronic Wheezing Illness. Children (Basel) (2015) 0.77
CD8+ T-cell epitope mapping for pneumonia virus of mice in H-2b mice. J Virol (2013) 0.77
Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells. PLoS One (2014) 0.76
Mechanical ventilation drives inflammation in severe viral bronchiolitis. PLoS One (2013) 0.75
In Hot Pursuit of the First Vaccine Against Respiratory Syncytial Virus. Yonsei Med J (2016) 0.75
The Human Immune Response to Respiratory Syncytial Virus Infection. Clin Microbiol Rev (2017) 0.75
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med (1993) 5.67
Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine. J Immunol (1969) 3.49
Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus. N Engl J Med (1971) 3.13
Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus. N Engl J Med (1971) 2.62
Local antibody response to poliovaccine in the human female genital tract. J Immunol (1973) 2.30
Epidemic measles in young adults. Clinical, epidemiologic, and serologic studies. Ann Intern Med (1979) 2.29
Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res (1993) 2.22
Sales of nonprescription cold remedies: a unique method of influenza surveillance. Pediatr Res (1979) 2.22
The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med (1981) 2.15
Vaccination strategies for mucosal immune responses. Clin Microbiol Rev (2001) 1.98
Respiratory syncytial virus. Curr Probl Pediatr (1993) 1.93
Respiratory syncytial virus infection. Rapid diagnosis in children by use of indirect immunofluorescence. Am J Dis Child (1978) 1.90
Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine. J Immunol (1969) 1.90
Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol (1998) 1.88
Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J (1990) 1.88
Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab. Oncogene (2010) 1.88
Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr Res (2009) 1.86
Potential spectrum of etiological agents of viral enteritis in hospitalized infants. J Clin Microbiol (1983) 1.85
Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States. JAMA (1973) 1.73
Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr (1992) 1.70
Immunologic aspects of human colostrum and milk. III. Fate and absorption of cellular and soluble components in the gastrointestinal tract of the newborn. J Immunol (1977) 1.69
Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis. Lancet (2005) 1.68
Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children. J Pediatr (1996) 1.65
The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses. J Pediatr (1980) 1.63
Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol (1991) 1.60
Otitis media in children. I. The systemic immune response to nontypable Hemophilus influenzae. J Infect Dis (1989) 1.55
Rubella-virus infection in juvenile rheumatoid arthritis. Lancet (1975) 1.52
Arthritis associated with induced rubella infection. J Immunol (1971) 1.51
Immunologic aspects of human colostrum and milk. II. Characteristics of lymphocyte reactivity and distribution of E-rosette forming cells at different times after the onset of lactation. J Pediatr (1978) 1.44
Antiviral effect of flavonoids on human viruses. J Med Virol (1985) 1.43
Effect of enhanced ultraviolet germicidal irradiation in the heating ventilation and air conditioning system on ventilator-associated pneumonia in a neonatal intensive care unit. J Perinatol (2011) 1.40
Enzyme immunoassay with monoclonal antibodies for the detection of rotavirus in stool specimens. J Infect Dis (1985) 1.39
Mycoplasma pneumoniae infections and exanthems. J Pediatr (1975) 1.39
Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection. J Infect Dis (1979) 1.38
Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization. Infect Immun (1991) 1.38
Respiratory syncytial virus affects pulmonary function in BALB/c mice. J Infect Dis (1998) 1.38
Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus. Am J Respir Cell Mol Biol (1995) 1.36
Inducible translational regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection in pulmonary epithelial cells. J Virol (1996) 1.35
Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group. J Pediatr (1998) 1.34
Secretory antibody response to respiratory syncytial virus infection. Am J Dis Child (1981) 1.34
Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J Infect Dis (1990) 1.34
Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans. J Infect Dis (1977) 1.33
Immunologic aspects of hepatitis-associated antigen and antibody in human body fluids. J Immunol (1973) 1.32
Age-dependent rotavirus-enterocyte interactions. Proc Soc Exp Biol Med (1982) 1.31
Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis (1997) 1.31
Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. J Immunol (1996) 1.29
Rotavirus infection of cultured intestinal epithelial cells induces secretion of CXC and CC chemokines. Gastroenterology (1998) 1.29
The major component of IkappaBalpha proteolysis occurs independently of the proteasome pathway in respiratory syncytial virus-infected pulmonary epithelial cells. J Virol (1998) 1.28
Rapid diagnosis of parainfluenza virus infection in children. J Clin Microbiol (1982) 1.28
Persistent rotavirus infection in mice with severe combined immunodeficiency. J Virol (1987) 1.27
Extramucosal spread and development of hepatitis in immunodeficient and normal mice infected with rhesus rotavirus. J Virol (1990) 1.27
Rapid detection of poliovirus by reverse transcription and polymerase chain amplification: application for differentiation between poliovirus and nonpoliovirus enteroviruses. J Clin Microbiol (1993) 1.26
Cigarette smoking and risk of clinical relapse in patients with Crohn's disease. Am J Prev Med (1990) 1.26
Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees. J Immunol (1987) 1.23
Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. J Pediatr (1979) 1.23
Measles revaccination. Persistence and degree of antibody titer by type of immune response. Am J Dis Child (1978) 1.22
Characteristics of fusion of respiratory syncytial virus with HEp-2 cells as measured by R18 fluorescence dequenching assay. J Virol (1991) 1.22
Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis. J Pediatr (1986) 1.21
Mechanism of mucosal immunity to viral infections in gammaA immunoglobulin-deficiency syndromes. Proc Soc Exp Biol Med (1974) 1.21
Distribution of rotavirus antigen in intestinal lymphoid tissues: potential role in development of the mucosal immune response to rotavirus. Clin Exp Immunol (1988) 1.20
Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice. J Med Virol (2000) 1.20
Occurrence of respiratory syncytial virus subgroup A and B strains in Japan, 1980 to 1987. J Clin Microbiol (1988) 1.20
Defective regulation of immune responses in respiratory syncytial virus infection. J Immunol (1984) 1.20
In vitro correlates of cell-mediated immunity in human tonsils after natural or induced Rubella virus infection. J Infect Dis (1975) 1.20
Upper respiratory infections in asthma. J Allergy Clin Immunol (1983) 1.19
Screening for antisense modulation of dystrophin pre-mRNA splicing. Neuromuscul Disord (2002) 1.18
Strain-specific local and systemic cell-mediated immune responses to cytomegalovirus in humans. Infect Immun (1978) 1.18
Poliovirus antibody response in patients with acute leukemia. J Pediatr (1971) 1.16
The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection. N Engl J Med (1980) 1.15
The role of immunoglulins in the mechanism of mucosal immunity to virus infection. Pediatr Clin North Am (1970) 1.13
Immunologic aspects of human colostrum and milk. I. Distribution characteristics and concentrations of immunoglobulins at different times after the onset of lactation. J Pediatr (1978) 1.13
The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res (1988) 1.12
Mucosal immune response to poliovirus vaccines in childhood. Rev Infect Dis (1984) 1.12
Development of serum and intestinal antibody response to rotavirus after naturally acquired rotavirus infection in man. J Med Virol (1981) 1.11
Parainfluenza virus bronchiolitis. Epidemiology and pathogenesis. Am J Dis Child (1986) 1.11
Natural history of parainfluenza virus infection in childhood. J Pediatr (1982) 1.11
Cutaneous manifestations of tuberculosis. Clin Exp Dermatol (2007) 1.10
Otitis media in children: local immune response to nontypeable Haemophilus influenzae. Infect Immun (1989) 1.10
Vaccination by non-parenteral routes: characteristics of immune response. Dev Biol Stand (1976) 1.09
Typical, modified, and atypical measles. Arch Intern Med (1977) 1.09
Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection. J Med Virol (1989) 1.08
Antibody response to varicella-zoster virus after natural or vaccine-induced infection. J Infect Dis (1982) 1.08
Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatr (1982) 1.08
Effect of respiratory syncytial virus on adherence, colonization and immunity of non-typable Haemophilus influenzae: implications for otitis media. Int J Pediatr Otorhinolaryngol (1992) 1.06
Cell-mediated immunity to varicella-zoster virus infection in subjects with lymphoma or leukemia. J Pediatr (1979) 1.06
Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol (1999) 1.05